Prognostic Factors of Second and Third Line Chemotherapy Using 5-Fu With Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2011.43.4.236
Full Text
Open PDFAbstract
Available in full text
Date
December 27, 2011
Authors
Publisher
Korean Cancer Association